Search This Site:
Clinical Commissioning Groups Logo

JPC Bulletin

Bedfordshire and Luton Joint Prescribing Committee

Ref: JPC Bulletin 242
Bulletin Date: 26/02/20
Review Date: February 2023

Bulletin 242: Low Molecular Weight Heparins (LMWHs), Fondaparinux and Novel Oral Anticoagulants – Prescribing Guidance and Responsibilities

JPC Recommendations:

Aims

To support the prescribing and monitoring of treatment and prophylactic doses of LMWHs, Fondaparinux and NOACs across the primary/secondary care interface for venous thromboembolism (VTE).

To support primary care prescribers in the governance and safety of initiating and/or continuing the prescribing of these agents.

Objectives
  • Define the place in therapy of LMWH, Fondaparinux and NOACs for primary care prescribers.
  • Identify who is responsible for the initiation and continued supply (where relevant) of these agents thereby minimising confusion.
  • Ensure that these agents are used safely and appropriately across Bedfordshire and Luton CCGs.

See attached bulletin for full details

Additional Information:

Scroll to Top